Why Inovio Pharmaceuticals (INO) Stock Is Down 40%
Why Inovio Pharmaceuticals (INO) Stock Is Down 40%
Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower by 40% to $2.23 during Friday's session after the company priced a public offering of 10 million shares of common stock and accompanying warrants.
伊諾維奧製藥公司（納斯達克：INO）的股票在週五的交易中下跌了40%，目前交易價格爲2.23美元，此前該公司以1000萬股普通股及相應的Warrants進行公開發行。
The shares are priced at $3.00 each, with warrants exercisable at $3.76 per share, potentially raising $30 million in gross proceeds before expenses and commissions.
每股定價爲3.00美元，Warrants的行使價格爲每股3.76美元，預計在扣除費用和佣金之前籌集3000萬美元的總收入。
The offering, managed by Oppenheimer & Co., Citizens JMP and Stephens Inc., is set to close on December 16, pending customary conditions.
此次發行由Oppenheimer & Co.、Citizens JMP和Stephens Inc.共同管理，預計將於12月16日結束，待滿足一般條件。
Read Also: Hershey Merger Talks Melt: Did High Cocoa Prices, Mondelez Buyback Program Hurt Deal?
另請閱讀：好時合併談判破滅：高可可價格和Mondelez回購計劃是否影響了交易？
Should I Sell My INO Stock?
我應該賣出我的INO股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或賣出股票時，投資者應考慮他們的時間跨度、未實現收益和總回報。
Shares of Inovio Pharmaceuticals have decreased by 51.14% in the past year. An investor who bought shares of Inovio Pharmaceuticals at the beginning of the year would take a loss of $4.49 per share if they sold it today. The stock has fallen 52.2% over the past month, meaning an investor who bought shares on Nov. 1 would see a capital loss of $3.24.
伊諾維奧製藥的股票在過去一年中下降了51.14%。如果一位投資者在年初購買了伊諾維奧製藥的股票，今天賣出將會損失每股4.49美元。該股票在過去一個月中下跌了52.2%，這意味着如果投資者在11月1日購買股票，將會看到每股3.24美元的資本損失。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
要訪問高級圖表和分析工具及股票數據，請查看Benzinga PRO。免費試用。
INO has a 52-week high of $14.75 and a 52-week low of $2.20.
伊諾維奧製藥的52周最高價爲14.75美元，最低價爲2.20美元。
